These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 11790939)

  • 1. Permanent cardiac pacing to prevent vasovagal syncope.
    Raj SR; Sheldon RS
    Curr Opin Cardiol; 2002 Jan; 17(1):90-5. PubMed ID: 11790939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of pacemakers in treating neurocardiogenic syncope.
    Raj SR; Sheldon RS
    Curr Opin Cardiol; 2003 Jan; 18(1):47-52. PubMed ID: 12496501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of pacing in the treatment of vasovagal syncope.
    Sheldon R
    Am J Cardiol; 1999 Oct; 84(8A):26Q-32Q. PubMed ID: 10568558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pacing to prevent vasovagal syncope.
    Sheldon R
    Cardiol Clin; 2000 Feb; 18(1):81-93. PubMed ID: 10709687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second Vasovagal Pacemaker Study (VPS II): rationale, design, results, and implications for practice and future clinical trials.
    Sheldon R; Connolly S;
    Card Electrophysiol Rev; 2003 Dec; 7(4):411-5. PubMed ID: 15071266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The North American Vasovagal Pacemaker Study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope.
    Connolly SJ; Sheldon R; Roberts RS; Gent M
    J Am Coll Cardiol; 1999 Jan; 33(1):16-20. PubMed ID: 9935002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DDD pacing with rate drop response function versus DDI with rate hysteresis pacing for cardioinhibitory vasovagal syncope.
    Ammirati F; Colivicchi F; Toscano S; Pandozi C; Laudadio MT; De Seta F; Santini M
    Pacing Clin Electrophysiol; 1998 Nov; 21(11 Pt 2):2178-81. PubMed ID: 9825314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II): a randomized trial.
    Connolly SJ; Sheldon R; Thorpe KE; Roberts RS; Ellenbogen KA; Wilkoff BL; Morillo C; Gent M;
    JAMA; 2003 May; 289(17):2224-9. PubMed ID: 12734133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pacing for vasovagal syncope after the second Vasovagal Pacemaker Study (VPS II): a matter of judgement.
    Trim GM; Krahn AD; Klein GJ; Skanes AC; Yee R
    Card Electrophysiol Rev; 2003 Dec; 7(4):416-20. PubMed ID: 15071267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Permanent pacing for recurrent vasovagal syncope: New answers or just more questions?
    Aksu T; Mandrola J; Raj SR
    J Electrocardiol; 2021; 65():88-90. PubMed ID: 33581411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Closed-loop cardiac pacing vs. conventional dual-chamber pacing with specialized sensing and pacing algorithms for syncope prevention in patients with refractory vasovagal syncope: results of a long-term follow-up.
    Palmisano P; Zaccaria M; Luzzi G; Nacci F; Anaclerio M; Favale S
    Europace; 2012 Jul; 14(7):1038-43. PubMed ID: 22247273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blind, placebo-controlled study of permanent cardiac pacing for the treatment of recurrent tilt-induced vasovagal syncope. The vasovagal syncope and pacing trial (SYNPACE).
    Raviele A; Giada F; Menozzi C; Speca G; Orazi S; Gasparini G; Sutton R; Brignole M;
    Eur Heart J; 2004 Oct; 25(19):1741-8. PubMed ID: 15451153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The vasovagal Syncope and pacing (Synpace) trial: rationale and study design.
    Raviele A; Giada F; Sutton R; Alboni P; Brignole M; Del Rosso A; Di Girolamo E; Luise R; Menozzi C
    Europace; 2001 Oct; 3(4):336-41. PubMed ID: 11678394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective randomized study comparing permanent pacing with rate drop response and closed loop stimulation in patients with vasovagal syncope where permanent pacing is indicated and selected as the appropriate treatment option.
    Prakash A; Sutton R
    J Cardiovasc Electrophysiol; 2023 Aug; 34(8):1744-1749. PubMed ID: 37393604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope: a multicenter, randomized, controlled trial.
    Ammirati F; Colivicchi F; Santini M;
    Circulation; 2001 Jul; 104(1):52-7. PubMed ID: 11435337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience with Thera DR rate-drop response pacing algorithm in carotid sinus syndrome and vasovagal syncope. The International Rate-Drop Investigators Group.
    Benditt DG; Sutton R; Gammage MD; Markowitz T; Gorski J; Nygaard GA; Fetter J
    Pacing Clin Electrophysiol; 1997 Mar; 20(3 Pt 2):832-9. PubMed ID: 9080522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications of mechanism of bradycardia on response to pacing in patients with unexplained syncope.
    Sud S; Klein GJ; Skanes AC; Gula LJ; Yee R; Krahn AD
    Europace; 2007 May; 9(5):312-8. PubMed ID: 17376795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expectation effect and cardiac pacing for refractory vasovagal syncope.
    Sud S; Massel D; Klein GJ; Leong-Sit P; Yee R; Skanes AC; Gula LJ; Krahn AD
    Am J Med; 2007 Jan; 120(1):54-62. PubMed ID: 17208080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Rate-drop response" cardiac pacing for vasovagal syncope. Rate-Drop Response Investigators Group.
    Benditt DG; Sutton R; Gammage M; Markowitz T; Gorski J; Nygaard G; Fetter J
    J Interv Card Electrophysiol; 1999 Mar; 3(1):27-33. PubMed ID: 10354973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasovagal syncope with asystole: the role of cardiac pacing.
    Brignole M; Tomaino M; Gargaro A
    Clin Auton Res; 2017 Aug; 27(4):245-251. PubMed ID: 28669088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.